✦ LIBER ✦

Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin

✍ Scribed by Jane L. Holley; Mike Elmore; Margaret Mauchline; Nigel Minton; Richard W. Titball

Book ID: 117429916
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 613 KB
Volume: 19
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(00)00155-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fermentation, Purification, and Efficacy

Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris

✍ Michael P. Byrne; Richard W. Titball; Jane Holley; Leonard A. Smith 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Expression and purification of catalytic

Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A

✍ John A. Chaddock; Michael H. Herbert; Roger J. Ling; Frances C.G. Alexander; Sar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Protection conferred by a fully recombin

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains

✍ S.M Jones; F Day; A.J Stagg; E.D Williamson 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Evaluation of chemical degradation of a

Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry

✍ Tia Estey; Christina Vessely; Theodore W. Randolph; Ian Henderson; LaToya Jones 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

Vaccines utilizing recombinant protein antigens typically require an adjuvant to enhance immune response in the recipients. However, the consequences of antigen binding to adjuvant on both the short-and long-term stability of the protein remain poorly defined. In our companion paper (Vessely et al.,

Construction and preclinical evaluation

Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli

✍ Kenneth L. Roland; Cheryl Cloninger; Sims K. Kochi; Lawrence J. Thomas; Steven A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Evaluation of cell-mediated immune respo

Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine

✍ Maria Fort; Marina Sibila; Miquel Nofrarías; Eva Pérez-Martín; Alex Olvera; Enri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 250 KB